Fernando Sánchez López

Statistics

Publications

Citations

287

H-Index

Active since

2004

Affiliations

Baylor University(Current)

Cleveland Clinic

Alexion Pharmaceuticals (United States)

Biogen (United States)

Multiple Sclerosis Society

Fernando Sánchez López is an author at Baylor University specializing in multiple sclerosis therapy, multiple sclerosis pharmacotherapy, and relapsing-remitting multiple sclerosis treatment.

ORCID

Publications per year

2004–2020

Publications

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

David H. Miller, Robert J. Fox, J. Theodore Phillips et al. · Neurology · 2015 · 65 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Corticosteroids, ibuprofen, and acetaminophen for IFNβ-1a flu symptoms in MS

Jordi Río, Carlos Nos, I Bonaventura et al. · Neurology · 2004 · 46 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Unemployment and Growth in the Tourism Sector in Mexico: Revisiting the Growth-Rate Version of Okun’s Law

Fernando Sánchez López · Economies · 2019 · 21 citations · Full text

Social Sciences, Economics, Economic Policy +11

1–5 of 6